Novartis takes aim at Roche's star MS drug

Novartis takes aim at Roche's star MS drug

Source: 
Reuters
snippet: 

Swiss drugmaker Novartis on Friday stepped up its challenge to Roche’s multiple sclerosis franchise, highlighting study results for its MS hopeful ofatumumab that could compete with its cross-town rival’s drug Ocrevus.